Evercyte
Evercyte provides human cell lines, in vitro test systems, and extracellular vesicle products for biotechnology and biomedical applications.
About
Evercyte specializes in developing and providing human telomerized cell lines, standardized in vitro test systems, and scalable extracellular vesicle (EV) production platforms for research, biotechnology, and clinical applications. The company enables researchers to circumvent limitations of primary cells using hTERT immortalization technology, offering advanced test models for toxicity, potency, drug testing, and organ-on-a-chip systems. Evercyte is committed to reducing animal testing by supplying relevant cell-based systems and collaborates broadly to accelerate innovation in preclinical research and clinical translation.
Products & Services
- human telomerized cell lines (catalogued by cell type and tissue)
- off-the-shelf extracellular vesicles from mesenchymal stromal cells
- cell factories for production of extracellular vesicles (EVs)
- customized cell line development (life span extension, reprogramming, iPSC creation)
- drug screening for cytotoxicity, potency, senolytic/senomorphic activity
- EV enrichment and potency testing
- gene editing services (knock-in/knock-out, reporter cell line establishment)
- ready-to-use cell culture media
- assay-ready cells
Use Cases & Case Studies
- 3D imaging of RPTEC/TERT1 in microphysiological systems
- Screening for substances with senolytic activity
- Scratch assay for monitoring skin cell proliferation/migration
- Study of myofibroblast differentiation in fibroblasts and effect of exogenous factors
- Testing for cytokine targeting (e.g., IL-17A)
- Optimization of cytotoxicity assays with P-MSC/TERT308 cell model
- 3D spheroid assays for angiogenesis modulation and drug screening
Partnerships & Collaborations
- Collaboration with Nortis on a kidney-on-a-chip model using telomerized human renal epithelial cells (RPTEC/TERT1)
- Partnership with Singapore-based AIM Biotech for development of advanced 3D angiogenesis assay kits and organ-on-a-chip systems
- Collaboration with TAmiRNA and Phoenestra on the EVscale™ platform for scalable EV production and characterization
- Partnership with MDimune Inc. (South Korea) to develop tumor-targeting EVs
- Participation in the EU-funded LifeSaver Project (maternal and fetal health)
- Participation in the CHANGE project (extracellular vesicles and ageing)
- Partnership with Chameleon Science for product distribution
Awards & Recognition
-
Contact Information
Certifications & Compliance
- GCCP (Good Cell Culture Practice)